While MALAT1 may have a less direct role in this cell death pathway in liver cancer, it may affect lung cancer patients' responsiveness to medicines that cause cuproptosis by controlling genes associated with mitochondrial activity [271]. The gene discussed is MALAT1; the disease is liver cancer.